This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Compared to Estimates, ICE (ICE) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for ICE (ICE) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
IntercontinentalExchange (ICE) Meets Q3 Earnings Estimates
by Zacks Equity Research
ICE (ICE) delivered earnings and revenue surprises of 0% and 0.13%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Agnico Eagle Mines and Brunswick have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Agnico Eagle Mines and Brunswick have been highlighted as Zacks Bull and Bear of the Day
Provident Financial (PFS) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Provident Financial (PFS) delivered earnings and revenue surprises of -21.74% and 0.33%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Will Intercontinental Exchange Pull Off a Surprise in Q3 Earnings?
by Zacks Equity Research
ICE's Q3 results are likely to reflect pricing and reference data business growth, strength in index business, higher commodities volume and financials volume.
Buy 2 Large-Cap Stocks Set to Beat on Q3 Earnings With Strong Upside
by Nalak Das
We have narrowed our search to two large-cap stocks set to report earnings results this month. These are: ICE, RBLX.
ICE (ICE) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Evaluate the expected performance of ICE (ICE) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CBOE Global (CBOE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CBOE (CBOE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nasdaq Tops Q3 Earnings Estimates, Tweaks Expense Guidance
by Zacks Equity Research
NDAQ's third-quarter results reflect broad-based growth across three divisions and another quarter of double-digit Solutions growth.
IntercontinentalExchange (ICE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
ICE (ICE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CME Group Q3 Earnings and Revenues Beat Estimates on Higher Volumes
by Zacks Equity Research
CME's third-quarter results reflect record trading volumes. Average daily volume increased in its six asset classes, with average daily volume up 20% in commodities and 28% in financial markets.
Here's Why IntercontinentalExchange (ICE) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does IntercontinentalExchange (ICE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Can CME Group Retain its Beat Streak This Earnings Season?
by Zacks Equity Research
A diverse product portfolio, increased volatility and a strong market position are likely to have aided CME's performance in the third quarter.
Nasdaq Gears Up to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
NDAQ's Q3 performance is likely to have been driven by organic revenue growth, new sales, higher segmental revenues and contributions from acquisitions.
ICE Trading at Premium to Industry at 24.93X: What Should You Do?
by Tanuka De
Investors who already hold Intercontinental Exchange stock should retain it and new investors can wait for a better entry point given its growth prospects.
CME Stock Trading at Discount to Industry at 22.46X: Should You Buy?
by Tanuka De
Solid global presence, a compelling product portfolio, increased electronic trading and a focus on over-the-counter clearing services poise CME Group for growth.
Top Analyst Reports for NextEra Energy, Lockheed Martin & Palo Alto Networks
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NextEra Energy, Inc. (NEE), Lockheed Martin Corporation (LMT) and Palo Alto Networks, Inc. (PANW), as well as two micro-cap stocks Rave Restaurant Group, Inc. (RAVE) and AXIL Brands, Inc. (AXIL).
Nasdaq Trading Near 52-Week High: How Should You Play the Stock?
by Zacks Equity Research
NDAQ is poised to gain from impressive organic growth, strategic buyouts to capitalize on growing market opportunities and effective capital deployment.
CBOE Stock Trading at Discount to Industry at 22.50X: Should You Buy?
by Tanuka De
A diversified business mix with recurring revenues, accelerated growth banking on recurring non-transaction revenues, use of technology and prudent buyouts poise Cboe Global well for growth.
Zacks Industry Outlook Intercontinental Exchange, CME Group, Nasdaq, Cboe Global and MarketAxess
by Zacks Equity Research
Intercontinental Exchange, CME Group, Nasdaq, Cboe Global and MarketAxess have been highlighted in this Industry Outlook article.
5 Securities and Exchanges Stocks to Watch Amid Market Volatility
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, NDAQ, CBOE and MKTX. However, compliance with regulations remains a challenge.
Intercontinental Stock Near 52-Week High: What Investors Should Know?
by Tanuka De
ICE benefits from a solid portfolio, a wide range of risk management services, cost synergies and a solid capital position.
CME Group Lags Industry in a Year: Is the Stock a Hold or Fold?
by Zacks Equity Research
Solid global presence, a compelling product portfolio, increased electronic trading and a focus on over-the-counter clearing services poise CME for growth.
Beat the Market Like Zacks: CareDx, Fair Isaac, 3M in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Take the Zacks Approach to Beat the Markets: New Jersey Resources, Axon, Coca-Cola in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.